| Hackensack Eye Surgery Center | |
| 385 Prospect Ave, Ste 300&302, Hackensack, New Jersey 07601 | |
| (201) 342-5191 |
| Name | Hackensack Eye Surgery Center |
|---|---|
| Organization Name | Associated Retinal Consultants Llc |
| Location | 385 Prospect Ave, Ste 300&302, Hackensack, New Jersey 07601 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (201) 342-5191 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
NPR's "News & Notes" on Tuesday included a discussion with Daniel Halperin, a senior research scientist in the Department of Population and International Health at the Harvard School of Public Health, about a recent study that recommended a shift in HIV prevention strategies in Africa toward the promotion of male circumcision and partner reduction programs.
GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira(TM) (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
The Muscular Dystrophy Association (MDA) and The ALS Association today announced a joint commitment to provide funding for a phase 2 clinical trial that will test efficacy of the NeuRx Diaphragm Pacing System (DPS) in people with amyotrophic lateral sclerosis (ALS).
› Verified 1 days ago
| NPI Number | 1205478765 |
| Organization Name | ASSOCIATED RETINAL CONSULTANTS LLC |
| Doing Business As | HACKENSACK EYE SURGERY CENTER |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 385 Prospect Ave Ste 300302, Hackensack, NJ 07601 |
| Phone Number | 201-342-5191 |
News Archive
NPR's "News & Notes" on Tuesday included a discussion with Daniel Halperin, a senior research scientist in the Department of Population and International Health at the Harvard School of Public Health, about a recent study that recommended a shift in HIV prevention strategies in Africa toward the promotion of male circumcision and partner reduction programs.
GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira(TM) (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
The Muscular Dystrophy Association (MDA) and The ALS Association today announced a joint commitment to provide funding for a phase 2 clinical trial that will test efficacy of the NeuRx Diaphragm Pacing System (DPS) in people with amyotrophic lateral sclerosis (ALS).
› Verified 1 days ago
News Archive
NPR's "News & Notes" on Tuesday included a discussion with Daniel Halperin, a senior research scientist in the Department of Population and International Health at the Harvard School of Public Health, about a recent study that recommended a shift in HIV prevention strategies in Africa toward the promotion of male circumcision and partner reduction programs.
GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira(TM) (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
The Muscular Dystrophy Association (MDA) and The ALS Association today announced a joint commitment to provide funding for a phase 2 clinical trial that will test efficacy of the NeuRx Diaphragm Pacing System (DPS) in people with amyotrophic lateral sclerosis (ALS).
› Verified 1 days ago
Pharmacy Plus & Surgical Supplies Type: Community/Retail Pharmacy Location: 57 Linden St, Hackensack, New Jersey 07601 Phone: (201) 968-5260 | |
Rite Aid Pharmacy 02463 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 219 Essex St, Hackensack, New Jersey 07601 Phone: (201) 488-7224 | |
Cvs Pharmacy #06076 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 110 Main St, Hackensack, New Jersey 07601 Phone: (201) 487-0092 | |
Cvs Pharmacy #16671 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 630 Main St, Hackensack, New Jersey 07601 Phone: (201) 678-0569 | |
Cvs Pharmacy #00129 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 101 Polifly Rd, Hackensack, New Jersey 07601 Phone: (201) 525-1149 |